Edwards Lifesciences

This study tested a new device called the Edwards PASCAL system to repair leaky mitral valves in the heart without open surgery. It involved 124 people with moderate-to-severe mitral regurgitation who were not good candidates for surgery. The device was placed using a thin tube t…

This study looked at whether a new way of processing heart valves (made from cow tissue) is safe and works well for people who need a new aortic or mitral valve. About 777 adults took part, and researchers checked for valve problems and side effects up to 5 years after surgery. T…

This study looked at how safe and effective the SAPIEN 3 heart valve is for Chinese patients with severe aortic stenosis (a narrowed heart valve) who are too high-risk for open-heart surgery. Fifty-eight patients received the valve through a less invasive procedure called TAVI. T…

This study tested a new heart valve (SAPIEN XT) in 57 people whose surgically-placed valve or tube between the heart and lungs was not working properly. The goal was to see if the valve could safely reduce leakage or blockage without needing another open-heart surgery. The study …

This study tested a device called PASCAL to repair a leaky tricuspid heart valve in 65 people with severe symptoms despite medication. The goal was to see if the device is safe and works well. It is an early feasibility study, not a cure, but aims to control the disease and impro…

This study tested whether smart alerts from a monitoring system help doctors follow a blood pressure management plan during major surgery. The goal was to see if this approach could reduce kidney injury. Researchers compared results from 296 patients to historical data.

This study tested a new blood pressure monitor called ClearSight NextGen in 35 adults having surgery. The goal was to collect blood pressure data to help improve the device. Participants wore the new monitor along with standard monitors to compare readings.